![Sean Bohen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sean Bohen
Algemeen Directeur bij
OLEMA PHARMACEUTICALS, INC.
Vermogen: 2 M $ op 30-09-2026
Profiel
Dr. Sean P.
Bohen is a President, Chief Executive Officer & Director at Olema Pharmaceuticals, Inc. He is on the Board of Directors at Gyroscope Therapeutics Ltd., Olema Pharmaceuticals, Inc. and AltruBio, Inc. Dr. Bohen was previously employed as a Non-Executive Director by Gyroscope Therapeutics Holdings Plc, a Chief Medical Officer & Executive Vice President by AstraZeneca PLC, a Senior Vice President-Early Development by Genentech, Inc., and an Associate by Howard Hughes Medical Institute, Inc. He received his undergraduate degree from the University of Wisconsin and a doctorate degree from The University of California, San Francisco.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 23-04-2026 | 237.650 ( 0,27% ) | 2 M $ | 30-09-2026 |
Actieve functies van Sean Bohen
| Bedrijven | Functie | Begin |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Algemeen Directeur | 01-09-2020 |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Directeur/Bestuurslid | 11-09-2020 |
Altrubio, Inc.
 Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Directeur/Bestuurslid | 01-08-2019 |
Eerdere bekende functies van Sean Bohen
| Bedrijven | Functie | Einde |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Directeur/Bestuurslid | 17-02-2022 |
| ASTRAZENECA PLC | Hoofd Techniek/Wetenschap/O&O | 14-01-2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01-07-2015 |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | 01-01-2003 |
Opleiding van Sean Bohen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
94
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Health Technology |
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Health Technology |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
